EFX.NYSEEquifax INC

Form 4: Equifax EVP Rodolfo Ploder Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Equifax's EVP, Rodolfo Ploder, executed sales of common stock on April 26, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • On April 26, 2024, Rodolfo O. Ploder, EVP at Equifax Inc., sold shares of common stock.
  • The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 15, 2023.
  • Ploder sold 550 shares at a weighted average price of $227.1105, with prices ranging from $226.79 to $227.49.
  • An additional 3,935 shares were sold at a weighted average price of $225.981, with prices ranging from $225.74 to $226.54.
  • Furthermore, 9,612 shares were sold at a weighted average price of $225.132, with prices ranging from $224.595 to $225.56.
  • Ploder also exercised a stock option to buy 10,697 shares at $149.53.
  • Following these transactions, Ploder directly owns 75,964 shares of common stock and indirectly owns 449 shares through a 401(k).
  • He also owns derivative securities representing the right to buy 7,134 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reflects routine insider trading activity under a pre-arranged plan. There's no indication of positive or negative sentiment towards the company's prospects.

Industry Context

This filing is a routine disclosure of insider transactions. It's common for executives to utilize 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information. The filing itself doesn't necessarily indicate a positive or negative outlook for the company.

Stakeholder Impact

  • The stock sales by an executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
08/15/2023Date the reporting person adopted the rule 10b5-1 trading plan
02/22/2022Date the stock option/right to buy was exercisable
02/22/2025Expiration date of the stock option/right to buy
04/26/2024Date of the transactions (stock sales and option exercise)
04/30/2024Date of the signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.